Vorinostat Recruiting Phase 1 Trials for Juvenile Myelomonocytic Leukemia / Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) / Mixed Phenotype Acute Leukemia (MPAL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03843528Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation